1-Pyrazin-2-yl-piperidin-3-ylaMine hydrochloride, 98+% C9H15ClN4, MW: 214.69
![]() |
- $315 - $498.11
- Product name: 1-Pyrazin-2-yl-piperidin-3-ylaMine hydrochloride, 98+% C9H15ClN4, MW: 214.69
- CAS: 1185319-30-5
- MF: C9H15ClN4
- MW: 214.6952
- EINECS:
- MDL Number:MFCD09607859
- Synonyms:1-Pyrazin-2-yl-piperidin-3-ylaMine hydrochloride, 98+% C9H15ClN4, MW: 214.69;1-(2-Pyrazinyl)-3-piperidinamine hydrochloride;1-Pyrazin-2-yl-piperidin-3-ylamine
4 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 5MG
- 500mg
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0237443
- Product description1-PYRAZIN-2-YL-PIPERIDIN-3-YLAMINE HYDROCHLORIDE 95.00%
- Packaging5MG
- Price$498.11
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM168895
- Product description1-(Pyrazin-2-yl)piperidin-3-aminehydrochloride 95%
- Packaging1g
- Price$456
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11338244
- Product description1-(Pyrazin-2-yl)piperidin-3-aminehydrochloride 95+%
- Packaging1g
- Price$482
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number060869
- Product description1-Pyrazin-2-ylpiperidin-3-amine dihydrochloride
- Packaging500mg
- Price$315
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0237443 | 1-PYRAZIN-2-YL-PIPERIDIN-3-YLAMINE HYDROCHLORIDE 95.00% | 5MG | $498.11 | 2021-12-16 | Buy |
Chemenu | CM168895 | 1-(Pyrazin-2-yl)piperidin-3-aminehydrochloride 95% | 1g | $456 | 2021-12-16 | Buy |
Crysdot | CD11338244 | 1-(Pyrazin-2-yl)piperidin-3-aminehydrochloride 95+% | 1g | $482 | 2021-12-16 | Buy |
Matrix Scientific | 060869 | 1-Pyrazin-2-ylpiperidin-3-amine dihydrochloride | 500mg | $315 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|